查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球局部給藥市場~2027年：按產品、給藥途徑、最終用戶、分銷渠道、地區、市場預測、增長機會的競爭分析
市場調查報告書
商品編碼
1101535

全球局部給藥市場~2027年：按產品、給藥途徑、最終用戶、分銷渠道、地區、市場預測、增長機會的競爭分析

Global Topical Drug Delivery Market, By Product By Route of Administration By End-User By Distribution Channel By Region, Competition Forecast & Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 118 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球局部給藥市場預計在預測期內將以穩定的複合年增長率增長。

全球燒傷病例增加和透皮給藥系統進步等因素正在推動市場需求。此外，非侵入性治療因其成本效益和患者快速康復而受到青睞，預計將進一步影響未來五年的市場增長。

按產品劃分，半固體製劑行業領先市場，預計在預測期內將保持其地位。增加的手術和器官移植正在推動該行業的需求。

本報告調查了全球局部給藥市場，包括市場概況、市場規模趨勢/預測、按類別/地區/主要國家分類的細分、市場上各種影響因素的分析、競爭環境、市場份額、主要公司簡介等

第一章產品概述

第二章調查方法

第 3 章執行摘要

第 4 章 COVID-19 對全球局部給藥市場的影響

第五章客戶反饋

第 6 章全球本地藥物輸送市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 副產品（半固體產品、液體產品、固體產品、透皮產品）
    • 通過給藥途徑（經皮、眼科、直腸、陰道、鼻腔）
    • 按最終用戶（醫院、診所、家庭保健、診斷中心等）
    • 按分銷渠道（線上/線下）
    • 按公司
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
  • 產品市場圖

第 7 章北美局部給藥市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按給藥途徑
    • 最終用戶
    • 按分銷渠道
    • 按國家/地區

第 8 章歐洲局部給藥市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按給藥途徑
    • 最終用戶
    • 按分銷渠道
    • 按國家/地區

第 9 章亞太地區局部給藥市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按給藥途徑
    • 最終用戶
    • 按分銷渠道
    • 按國家/地區

第 10 章中東和非洲局部給藥市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按給藥途徑
    • 最終用戶
    • 按分銷渠道
    • 按國家/地區

第 11 章南美本地藥物輸送市場展望

  • 市場規模/預測
  • 市場份額/預測
    • 按產品
    • 按給藥途徑
    • 最終用戶
    • 按分銷渠道
    • 按國家/地區

第12章市場動態

  • 促進因素
  • 挑戰

第 13 章市場趨勢/市場發展

第14章競爭態勢

  • 競爭前景
  • 全球公司簡介（主要公司）
    • Johnson & Johnson SA
    • Nestle SA
    • GlaxoSmithKline Plc
    • Novartis AG
    • Merck & Co. Inc.
    • Crescita Therapeutics Inc.
    • Cipla Ltd.
    • Taro Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals International Inc.
    • Glenmark Pharmaceuticals Ltd.
    • Bayer AG
    • Encore Dermatology, Inc.
    • MedPharm Group Ltd.
    • Skinvisible Pharmaceuticals, Inc.
    • Galderma S.A.

第15章 策略建議

簡介目錄
Product Code: 7362

The global topical drug delivery market is anticipated to witness a growth with a steady CAGR in the forecast period, 2023-2027. Factors such as increased incidence of burn injuries across the globe and advancements in the transdermal drug delivery systems are primarily driving the market demand. The rise at the old age population who prefer to use tropical drug delivery as it eases the drug delivery process fuels the market demand. Also, the growing popularity of the non-invasive procedures due to their cost-effectiveness and fast healing among patients is further expected to influence the market growth in the next five years.

The global topical drug delivery market is segmented into product, route of administration, end user, distribution channel, regional distribution, and competitive landscape. Based on product, the market is fragmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations dominate the market and are anticipated to maintain their dominance over the forecast period, 2023-2027. Lotions, creams, gels, pastes, ointments, and other semi-solid formulations are some examples of semi-solid formulations that are used topically. These formulations are absorbed through the skin, and the therapeutic ingredients do the same, penetrating the skin to enter the body's bloodstream through tiny capillaries. They fix any damage or abnormality in the epidermal tissues that cover the surface of the body. The rise in the number of surgeries and organ transplantation procedures is driving the segment demand.

The major market players operating in the global topical drug delivery market are Johnson & Johnson SA, Nestle SA, GlaxoSmithKline Plc, Novartis AG, Merck & Co. Inc., Crescita Therapeutics Inc., Cipla Ltd., Taro Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Glenmark Pharmaceuticals Ltd., Bayer AG, Encore Dermatology, Inc., MedPharm Group Ltd., Skinvisible Pharmaceuticals, Inc., and Galderma S.A.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F-2027F

Objective of the Study:

  • To analyze the historical growth in the market size of global topical drug delivery market from 2017 to 2021.
  • To estimate and forecast the market size of global topical drug delivery market from 2022E to 2027F and growth rate until 2027F.
  • To classify and forecast global topical drug delivery market based on product, route of administration, end user, distribution channel, regional distribution, and competitional landscape.
  • To identify dominant region or segment in the global topical drug delivery market.
  • To identify drivers and challenges for global topical drug delivery market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global topical drug delivery market.
  • To identify and analyze the profile of leading players operating in global topical drug delivery market.
  • To identify key sustainable strategies adopted by market players in global topical drug delivery market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies, suppliers, and service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global topical drug delivery market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • End users, service providers and other stakeholders
  • Distributers and suppliers of topical drugs and other stakeholders
  • Organizations, forums, and alliances related to topical drug delivery market
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global Topical Drug Delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Topical Drug Delivery Market, By Product:

Semi-Solid Formulations

Liquid Formulations

Solid Formulations

Transdermal Products

  • Global Topical Drug Delivery Market, By Route of Administration:

Dermal Drug Delivery

Ophthalmic Drug Delivery

Rectal Drug Delivery

Vaginal Drug Delivery

Nasal Drug Delivery

  • Global Topical Drug Delivery Market, By Distribution Channel:

Online

Offline

  • Global Topical Drug Delivery Market, By End User:

Hospitals

Clinics

Home Healthcare

Diagnostic Centers

Others

  • Global Topical Drug Delivery Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global topical drug delivery market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Topical Drug Delivery Market

5. Voice of Customer

6. Global Topical Drug Delivery Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
    • 6.2.2. By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery)
    • 6.2.3. By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others)
    • 6.2.4. By Distribution Channel (Online vs. Offline)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
  • 6.3. Product Market Map

7. North America Topical Drug Delivery Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By End User
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Country (United States; Canada; Mexico)
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Topical Drug Delivery Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Distribution Channel
    • 7.3.2. Canada Topical Drug Delivery Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By End User
        • 7.3.2.2.4. By Distribution Channel
    • 7.3.3. Mexico Topical Drug Delivery Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By End User
        • 7.3.3.2.4. By Distribution Channel

8. Europe Topical Drug Delivery Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By End User
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Country (France; Germany; UK; Italy; Spain)
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Topical Drug Delivery Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By End User
        • 8.3.1.2.4. By Distribution Channel
    • 8.3.2. Germany Topical Drug Delivery Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By End User
        • 8.3.2.2.4. By Distribution Channel
    • 8.3.3. United Kingdom Topical Drug Delivery Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By End User
        • 8.3.3.2.4. By Distribution Channel
    • 8.3.4. Italy Topical Drug Delivery Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By End User
        • 8.3.4.2.4. By Distribution Channel
    • 8.3.5. Spain Topical Drug Delivery Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By End User
        • 8.3.5.2.4. By Distribution Channel

9. Asia-Pacific Topical Drug Delivery Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By End User
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Country (China; India; Japan; South Korea; Australia)
  • 9.3. Asia Pacific: Country Analysis
    • 9.3.1. China Topical Drug Delivery Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By End User
        • 9.3.1.2.4. By Distribution Channel
    • 9.3.2. India Topical Drug Delivery Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By End User
        • 9.3.2.2.4. By Distribution Channel
    • 9.3.3. Japan Topical Drug Delivery Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By End User
        • 9.3.3.2.4. By Distribution Channel
    • 9.3.4. South Korea Topical Drug Delivery Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Route of Administration
        • 9.3.4.2.3. By End User
        • 9.3.4.2.4. By Distribution Channel
    • 9.3.5. Australia Topical Drug Delivery Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Route of Administration
        • 9.3.5.2.3. By End User
        • 9.3.5.2.4. By Distribution Channel

10. Middle East and Africa Topical Drug Delivery Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By End User
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Country (UAE; Saudi Arabia; South Africa)
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Topical Drug Delivery Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By End User
        • 10.3.1.2.4. By Distribution Channel
    • 10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By End User
        • 10.3.2.2.4. By Distribution Channel
    • 10.3.3. UAE Topical Drug Delivery Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By End User
        • 10.3.3.2.4. By Distribution Channel

11. South America Topical Drug Delivery Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Route of Administration
    • 11.2.3. By End User
    • 11.2.4. By Distribution Channel
    • 11.2.5. By Country (Brazil; Argentina; Colombia)
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Topical Drug Delivery Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Route of Administration
        • 11.3.1.2.3. By End User
        • 11.3.1.2.4. By Distribution Channel
    • 11.3.2. Argentina Topical Drug Delivery Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Route of Administration
        • 11.3.2.2.3. By End User
        • 11.3.2.2.4. By Distribution Channel
    • 11.3.3. Colombia Topical Drug Delivery Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Route of Administration
        • 11.3.3.2.3. By End User
        • 11.3.3.2.4. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Global Players Profiled (Leading Companies)
    • 14.2.1. Johnson & Johnson SA
    • 14.2.2. Nestle SA
    • 14.2.3. GlaxoSmithKline Plc
    • 14.2.4. Novartis AG
    • 14.2.5. Merck & Co. Inc.
    • 14.2.6. Crescita Therapeutics Inc.
    • 14.2.7. Cipla Ltd.
    • 14.2.8. Taro Pharmaceutical Industries Ltd.
    • 14.2.9. Valeant Pharmaceuticals International Inc.
    • 14.2.10. Glenmark Pharmaceuticals Ltd.
    • 14.2.11. Bayer AG
    • 14.2.12. Encore Dermatology, Inc.
    • 14.2.13. MedPharm Group Ltd.
    • 14.2.14. Skinvisible Pharmaceuticals, Inc.
    • 14.2.15. Galderma S.A.

15. Strategic Recommendations